{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042744","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2026-09-15T20:05:28+00:00","discovered_at":"2026-09-15T20:06:00.298019+00:00","generated_at":"2026-09-15T20:06:38.518098+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Co-Diagnostics signs MTA with ReadyGo to test sample prep tech on Co-Dx PCR platform","bullets":["In August 2026, Co-Diagnostics entered a material transfer agreement with ReadyGo Diagnostics Ltd to evaluate ReadyGo's sample collection/preparation tech.","Evaluation covers compatibility of ReadyGo's sample collection, lysis, stabilization, and prep technologies with Co-Dx PCR platform.","ReadyGo will supply sampling materials for feasibility studies; no obligation for further development, supply, or commercialization.","Co-Dx PCR platform and tests are not yet FDA-approved and are not currently available for sale."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042744","json":"https://secwatch.observer/filing/0001493152-26-042744.json","markdown":"https://secwatch.observer/filing/0001493152-26-042744.md","text":"https://secwatch.observer/filing/0001493152-26-042744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315226042744/0001493152-26-042744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315226042744/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-15T20:06:38.518098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}